今日药学2024,Vol.34Issue(8) :636-640.DOI:10.12048/j.issn.1674-229X.2024.08.014

利金方治疗慢性阻塞性肺疾病的作用机制探析

Analysis of the Mechanism of Li Jin Fang in Treating Chronic Obstructive Pulmonary Disease

黄武祯 陈斯宁 黎展华
今日药学2024,Vol.34Issue(8) :636-640.DOI:10.12048/j.issn.1674-229X.2024.08.014

利金方治疗慢性阻塞性肺疾病的作用机制探析

Analysis of the Mechanism of Li Jin Fang in Treating Chronic Obstructive Pulmonary Disease

黄武祯 1陈斯宁 2黎展华2
扫码查看

作者信息

  • 1. 广西中医药大学研究生院,广西南宁 530000
  • 2. 广西中医药大学附属瑞康医院呼吸与危重症科,广西南宁 530000
  • 折叠

摘要

慢性阻塞性肺疾病(COPD)是一种常见的呼吸系统疾病,涉及炎症反应、免疫功能紊乱、氧化应激等病理过程.COPD的临床病症归属于中医学"肺胀(lung distension)"范畴,根据"肺气虚"病机特点创制的利金方在多项临床研究中显示出良好疗效,也有多项动物实验从分子细胞学层面对利金方治疗COPD的作用机制进行了较深入的研究.本文就其作用机制进行归纳总结,为进一步实验研究及临床应用提供参考.

Abstract

Chronic obstructive pulmonary disease(COPD)is a common respiratory system disease that involves pathological processes such as inflammatory response,immune dysfunction,and oxidative stress.The clinical symptoms of COPD are categorized as"lung distension"in traditional Chinese medicine(TCM).Based on the TCM pathogenesis characteristicsof"lung Qi deficiency",the formula Li Jin Fang has shown good therapeutic effects in multiple clinical studies.There have also been multiple animal experiments that have conducted in-depth research on the mechanism by which Li Jin Fang treats COPD at the molecular and cellular levels.This article summarizes the mechanism of its action,providing a reference for further experimental research and clinical application.

关键词

利金方/慢性阻塞性肺疾病/作用机制/理论探讨

Key words

Li Jin Fang/chronic obstructive pulmonary disease/mechanisms of action/theoretical exploration

引用本文复制引用

基金项目

国家自然科学基金项目(82360908)

国家自然科学基金项目(81760853)

出版年

2024
今日药学
广东省药学会 中国药学会

今日药学

影响因子:0.413
ISSN:1674-229X
段落导航相关论文